Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. 2007

Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Japan.

OBJECTIVE Crossed cerebellar diaschisis (CCD) is defined as a depression of blood flow and oxidative metabolism of glucose in the cerebellum contralateral to a supratentorial brain lesion, as detected with positron emission tomography (PET) and single photon emission computed tomography. We examined whether L-[methyl-11C]methionine (MET) uptake is affected in CCD. METHODS In 12 patients with a unilateral supratentorial brain tumor, we evaluated the uptake of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) and MET in the cerebellar hemispheres by means of PET. Asymmetry index (AI) was defined as a difference in the average count between the ipsilateral and contralateral cerebellar hemispheres divided by the average count in both cerebellar hemispheres. Patients with AI of FDG PET more than 0.1 and those with AI equal to 0.1 or less than 0.1 were classified as CCD-positive and CCD-negative, respectively. RESULTS Six patients were CCD-positive and others were CCD-negative in the FDG PET study. Between CCD-positive and CCD-negative patients, mean AI of MET was not significantly different (0.017 +/- 0.023 and 0.014 +/- 0.039, respectively). CONCLUSIONS Different from glucose metabolism, cerebellar MET uptake was not affected in CCD. The present study may indicate that cerebellar MET uptake is independent of suppression of cerebellar neuronal activity.

UI MeSH Term Description Entries
D008297 Male Males
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002526 Cerebellar Diseases Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA. Cerebellar Dysfunction,Cerebellum Diseases,Cerebellar Disorders,Cerebellar Syndromes,Cerebellar Disease,Cerebellar Disorder,Cerebellar Dysfunctions,Cerebellar Syndrome,Cerebellum Disease,Disease, Cerebellar,Disease, Cerebellum,Disorder, Cerebellar,Dysfunction, Cerebellar,Syndrome, Cerebellar
D002531 Cerebellum The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills. Cerebella,Corpus Cerebelli,Parencephalon,Cerebellums,Parencephalons
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
January 1987, Kokyu to junkan. Respiration & circulation,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
January 1998, Journal of the neurological sciences,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
July 2002, Molecular imaging and biology,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
January 1991, Acta radiologica. Supplementum,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
January 2019, World journal of nuclear medicine,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
May 2022, Rheumatology (Oxford, England),
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
January 1985, Journal of computer assisted tomography,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
January 1987, Neuroradiology,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
April 2009, Journal of medical imaging and radiation oncology,
Katsufumi Kajimoto, and Naohiko Oku, and Yasuyuki Kimura, and Hiroki Kato, and Makiko Rai Tanaka, and Yasukazu Kanai, and Kazuo Kitagawa, and Motohiko Maruno, and Toshiki Yoshimine, and Masatsugu Hori, and Jun Hatazawa
June 2013, The American journal of the medical sciences,
Copied contents to your clipboard!